Active, not recruitingPHASE1, PHASE2NCT03919435
TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Studying Granulomatosis with polyangiitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Pennsylvania
- Intervention
- Trimethoprim Sulfamethoxazole(drug)
- Enrollment
- 8 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2027
Study locations (1)
- Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03919435 on ClinicalTrials.govOther trials for Granulomatosis with polyangiitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06940661Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With PolyangiitisAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGPHASE3NCT01933724The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric ApproachUniversity of South Florida